Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Woolly monkey sarcoma virus | Simian sarcoma virus Pol protein | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trypanosoma congolense | RNase H/Integrase core domain containing protein, putative | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Echinococcus multilocularis | pol protein | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Trypanosoma congolense | Integrase core domain containing protein, putative | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Echinococcus multilocularis | pol protein | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Echinococcus multilocularis | pol protein | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Echinococcus multilocularis | pol protein | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Trypanosoma congolense | Integrase core domain containing protein, putative | Get druggable targets OG5_134588 | All targets in OG5_134588 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0038 | 0.1069 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0038 | 0.1069 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0038 | 0.1069 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0038 | 0.1069 | 0.5 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.013 | 0.4779 | 0.4779 |
Echinococcus multilocularis | pol protein | 0.0259 | 1 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.1971 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0038 | 0.1069 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.1971 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.1971 | 0.4124 |
Mycobacterium leprae | putative cytochrome p450 | 0.0011 | 0 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0038 | 0.1069 | 0.2055 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0032 | 0.0847 | 0.7927 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0038 | 0.1069 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.1971 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0038 | 0.1069 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.013 | 0.4779 | 0.9191 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0038 | 0.1069 | 0.1069 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0038 | 0.1069 | 0.5 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.1971 | 0.1971 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0038 | 0.1069 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.1971 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0032 | 0.0847 | 0.7927 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.1971 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.014 | 0.52 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0038 | 0.1069 | 0.5422 |
Schistosoma mansoni | ap endonuclease | 0.0038 | 0.1069 | 0.2055 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.014 | 0.52 | 0.52 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.013 | 0.4779 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.1971 | 0.3791 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.1971 | 0.3791 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0038 | 0.1069 | 0.5422 |
Echinococcus multilocularis | pol protein | 0.0259 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0038 | 0.1069 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0038 | 0.1069 | 0.2236 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0038 | 0.1069 | 0.5422 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0038 | 0.1069 | 0.5 |
Echinococcus multilocularis | pol protein | 0.0259 | 1 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.1971 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0038 | 0.1069 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0038 | 0.1069 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.014 | 0.52 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0038 | 0.1069 | 0.5422 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.00001 M l-1 | Ability to inhibit simian sarcoma virus reverse transcriptase | ChEMBL. | 6154141 |
IC50 (binding) | = 0.00001 M l-1 | Ability to inhibit simian sarcoma virus reverse transcriptase | ChEMBL. | 6154141 |
IC50 (binding) | = 0.00012 M l-1 | Ability to inhibit mouse beta DNA polymerase | ChEMBL. | 6154141 |
IC50 (binding) | = 0.00012 M l-1 | Ability to inhibit mouse beta DNA polymerase | ChEMBL. | 6154141 |
IC50 (binding) | = 0.00014 M l-1 | Ability to inhibit mouse alpha DNA polymerase | ChEMBL. | 6154141 |
Log 1/C (binding) | = 5 | Inhibition of simian sarcoma virus reverse transcriptase | ChEMBL. | 6154141 |
Log 1/C (binding) | = 3.85 | The logarithm of the reciprocal of the concentration which produces 50% inhibition of mammalian alpha DNA polymerase. | ChEMBL. | 6154141 |
Log 1/C (binding) | = 3.92 | The logarithm of the reciprocal of the concentration which produces 50% inhibition of mammalian beta DNA polymerase. | ChEMBL. | 6154141 |
Log 1/C (binding) | = 5 | Inhibition of simian sarcoma virus reverse transcriptase | ChEMBL. | 6154141 |
logP (ADMET) | = 3.34 | Partition coefficient (logP) | ChEMBL. | 6154141 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.